The Hyperplasia of Pulmonary Arteriole Wall during Pulmonary Hypertension can be Interfered by Calcium Channel Blocking and Aspirin
Author:
  • Article
  • | |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • | |
  • Comments
    Abstract:

    Aim To observe whether the hyperplasia of pulmonary arteriole wall during pulmonary hypertension can be interfered by calcium channel-blocking. Methods Performed the anastomosis between left pulmonary artery and descending aorta in New Zealand rabbits, and banded the proximal left pulmonary artery of anastomosis, to establish the model of one-side kinetic pulmonary artery hypertension. After operation rabbits in drug group were fed with nifedipine and aspirin, and the blood concentration of endothelin and TXA2/PGI2 was measured regularly. Pulmonary artery pressure was measured and lung biopsy was performed in 2-3 months observation. Results During rabbits formatting pulmonary hypertension, those giving drugs got minor hyperplasia of pulmonary arteriole wall than those not giving drugs. The blood concentration of endothelin increased at all rabbits but the crest value was lower in drugs group. The ratio of TXA2/PGI2 was lower in drugs group too. Conclusion Calcium channel blocker can inhibit the hyperplasia of pulmonary arteriole wall during the formation of pulmonary hypertension, which could be the results that calcium channel blocking and aspirin inhibit the production of endothelin and TXA2 and promote the produce of PGI2.

    Reference
    Related
    Cited by
Get Citation

WANG Zhi-Ping, ZENG Ya-Hui,,YANG Da-Hua. The Hyperplasia of Pulmonary Arteriole Wall during Pulmonary Hypertension can be Interfered by Calcium Channel Blocking and Aspirin[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2001,9(4):302-305.

Copy
Related Videos

Share
Article Metrics
  • Abstract:1177
  • PDF: 1012
  • HTML: 0
  • Cited by: 0
History
  • Received:April 20,2001
  • Revised:September 27,2001
Article QR Code